Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson’s disease

Qian Ren,Min Ma,Jun Yang,Risa Nonaka,Akihiro Yamaguchi,Kei-ichi Ishikawa,Kenta Kobayashi,Shigeo Murayama,Sung Hee Hwang,Shinji Saiki,Wado Akamatsu,Nobutaka Hattori,Bruce D. Hammock,Kenji Hashimoto

DOI: https://doi.org/10.1073/pnas.1802179115

IF: 11.1

2018-05-07

Proceedings of the National Academy of Sciences

Abstract:Significance Parkinson’s disease (PD) is a chronic and progressive movement disorder; however, the precise mechanisms of its etiology remain largely unknown. Soluble epoxide hydrolase (sEH) plays a key role in the inflammation associated with PD pathogenesis. The sEH inhibitor or deletion of the sEH gene protected against MPTP-induced neurotoxicity in mouse brain. Furthermore, expression of the sEH protein (or mRNA) was higher in the striatum of MPTP-treated mice, patients with dementia of Lewy bodies (DLB), and neurons from iPSCs of a PD patient with PARKIN mutations. Interestingly, treatment with sEH inhibitor protected against apoptosis in human PARK2 iPSC-derived dopaminergic neurons. Our findings indicate that sEH inhibitors or epoxy fatty acids mimics may be promising prophylactic or therapeutic drugs for PD.